XBiotech Inc. (XBIT) Form 8-K — Oct 26, 2026

$XBITForm 8-KItems 5.02Filed Oct 26, 2026, 9:39 AM ET0001171843-26-006810Original filing

XBiotech's board appointed Dr. Sushma Shivaswamy and Jan-Paul Simard as Co-Chief Executive Officers effective October 23, 2026. Shivaswamy, a 17-year veteran and CSO since 2017, had been interim CEO since founder John Simard's retirement in December 2025. Jan-Paul Simard, age 24, is the founder's son and joined the company in 2012 as an R&D assistant before moving to clinical development in 2020.

Key figures

Option vesting: 1/6 at 180 days, then 1/6 every six months, fully vested within three years
Option term years: 10
Option grant shares: 2000000
Shivaswamy annual salary usd: 750000
Simard annual base salary usd: 150000

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.